Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  PuriCore plc    PURI   GB00B3XBCR18

PURICORE PLC (PURI)

2
Delayed Quote. Delayed London Stock Exchange - 03/05 11:35:07 am
30.5 GBp   --.--%
02/24 PURICORE : Expects Wider Loss As Revenue Falls Due To Model Shift
02/17 PURICORE : Blocklisting Interim Review
01/09 PURICORE : Holding(s) in Company
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
02/27/2015 03/02/2015 03/03/2015 03/04/2015 03/05/2015 Date
30.5(c) 30.5(c) 30.5(c) 30.5(c) 30.5 Last
0 19 762 480 6 666 0 Volume
0.00% 0.00% 0.00% 0.00% 0.00% Change
More quotes
Company
PuriCore Plc engages in the development and commercialization of antimicrobial solutions and complementary products.It caters to the supermarket retail and health sciences markets by offering products to supermarket retailers for use in the fresh produce department and solutions for treatment of... 
More about the company
Chart PURICORE PLC
Duration : Period :
PuriCore plc Technical Analysis Chart | PURI | GB00B3XBCR18 | 4-Traders
Full-screen chart
Financials ( GBP)
Sales 2014 31,7 M
EBIT 2014 -
Net income 2014 -
Debt 2014 -
Yield 2014 -
Sales 2015 38,3 M
EBIT 2015 -
Net income 2015 -
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 0,49x
Capi. / Sales 2015 0,40x
Capitalization 15,4 M
More Financials
Latest news on PURICORE PLC
02/24 PURICORE : Expects Wider Loss As Revenue Falls Due To Model Shift
02/17 PURICORE : Blocklisting Interim Review
01/09 PURICORE : Holding(s) in Company
2014 PURICORE : Mill Residential Floats On AIM, PuriCore Moves From Main Market (ALLI..
2014 PURICORE : commences trading on AIM
2014 PURICORE : commences trading on AIM
2014 PURICORE : Preliminary Decisions Arising From The On-Going Strategic And Operati..
2014 PURICORE : To Invest Disposal Cash Rather Than Return To Shareholders
More news
Sector news Biotechnology & Medical Research - NEC
02:22pDJMARKET SNAPSHOT : U.S. Stocks Flirt With Records Ahead Of Key Jobs Report
01:07p Wall St little changed after 2-day drop, data
01:01pDJAbbVie to Buy Pharmacyclics in $21 Billion Deal -- 4th Update
Plus d'actualités du secteur Biotechnology & Medical Research - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF